Your Client Rank:
Loading...
99
Updated 04-Feb-2026
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Ascendis | 35.1% | 0.5% | -19.7% | -21.5% | | | | |
| Lilly | 13.1% | 0.1% | -3.4% | -6.5% | 4.8% | -0.5% | 19.3% | 19.6% |
| Vertex | 9.3% | 0.2% | -2.4% | -5.0% | 1.6% | 3.2% | 10.5% | 10.6% |
| Daiichi | 8.6% | 1.3% | 1.7% | -4.3% | 5.4% | 2.3% | 13.1% | 12.8% |
| Eisai | 7.6% | -1.1% | -2.5% | -6.1% | 11.7% | -1.7% | 19.8% | 19.8% |
| Regeneron | 6.8% | 0.3% | -0.5% | -1.5% | 2.7% | 2.5% | 9.2% | 9.4% |
| Astra | 6.6% | 0.4% | -2.2% | -1.9% | 3.4% | 0.3% | 11.3% | 11.2% |
| Chugai | 6.1% | 1.4% | -3.2% | -1.2% | 3.1% | 0.3% | 9.3% | 9.0% |
| AbbVie | 6.0% | 0.2% | -2.7% | -7.7% | 5.0% | -0.6% | 12.9% | 13.0% |
| Novo | 5.8% | 0.4% | -0.5% | -1.5% | 1.9% | 0.1% | 6.6% | 7.3% |
| JNJ | 5.5% | 0.2% | -1.7% | -0.9% | 2.5% | 1.2% | 7.9% | 8.8% |
| Sanofi | 5.1% | 0.4% | -1.6% | -1.7% | 2.7% | 0.4% | 7.6% | 8.4% |
| Novartis | 3.9% | 0.0% | -0.4% | -0.4% | 0.7% | -0.2% | 4.8% | 5.8% |
| Roche | 3.8% | 0.1% | -0.6% | 0.5% | 2.2% | 0.3% | 6.5% | 6.6% |
| Gilead | 3.7% | -0.1% | -0.6% | -2.6% | 1.5% | 0.2% | 5.8% | 6.0% |
| Shionogi | 3.1% | -1.1% | 1.0% | -2.0% | -6.5% | 1.5% | -3.9% | -3.2% |
| Amgen | 2.7% | 0.0% | -0.8% | 0.4% | -0.2% | 0.4% | 3.8% | 3.9% |
| Teva | 2.4% | 1.1% | -1.1% | 0.4% | 2.1% | 0.4% | 7.0% | 6.5% |
| Bayer | 2.3% | | | | | -2.8% | 5.2% | 4.0% |
| Glaxo | 2.1% | -0.1% | -0.6% | -0.4% | 0.7% | 0.6% | 3.7% | 4.0% |
| Takeda | 2.0% | 0.3% | -1.0% | 0.9% | 13.2% | -7.0% | 6.9% | 5.8% |
| Merck | 1.9% | -0.1% | -0.2% | 0.2% | -0.5% | 2.8% | 1.5% | 2.2% |
| Biogen | -1.1% | 0.2% | 1.0% | -2.3% | 0.7% | 0.6% | 2.1% | 2.1% |
| Lundbeck | -2.1% | -0.8% | 0.5% | 3.7% | -4.0% | 1.0% | -4.6% | -3.7% |
| Pfizer | -3.3% | -0.1% | 1.0% | 1.2% | -2.3% | 4.3% | -6.0% | -6.1% |
| Bristol | -5.2% | 1.3% | 4.2% | -1.4% | 1.9% | 0.0% | -4.1% | -3.9% |
| Astellas | -5.8% | -0.9% | -2.9% | 3.5% | -1.5% | 1.6% | -5.6% | -6.7% |
| Neurocrine | | | | | | | | |
| EU Major | 4.3% | 0.1% | -0.8% | -0.6% | 2.4% | 0.4% | 6.8% | 7.3% |
| Other EU | 9.0% | 0.1% | -7.1% | -5.5% | 19.0% | -10.6% | 40.6% | |
| US Major | 4.2% | 0.4% | -1.2% | -3.0% | 3.0% | 1.1% | 7.5% | 11.9% |
| US Big Biotech | 4.1% | 0.2% | -1.1% | -1.4% | 1.1% | 1.1% | 6.1% | 7.4% |
| Other US | 2.4% | 1.1% | -1.1% | 0.4% | 2.1% | 0.4% | 7.0% | 6.5% |
| Japanese | 3.2% | 0.4% | -0.7% | -0.9% | 5.0% | 0.3% | 6.5% | 6.9% |
